Teva Pharmaceutical Industries Limited (TEVA) Stake Cut by Mitsubishi UFJ Kokusai Asset Management Co. Ltd.

Mitsubishi UFJ Kokusai Asset Management Co. Ltd. cut its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA) by 12.3% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 119,700 shares of the company’s stock after selling 16,816 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in Teva Pharmaceutical Industries Limited were worth $3,976,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of the company. Teachers Advisors LLC purchased a new stake in Teva Pharmaceutical Industries Limited during the fourth quarter valued at about $21,946,000. Chevy Chase Trust Holdings Inc. raised its position in shares of Teva Pharmaceutical Industries Limited by 3.4% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 6,273 shares of the company’s stock worth $201,000 after buying an additional 207 shares during the last quarter. National Pension Service raised its position in shares of Teva Pharmaceutical Industries Limited by 8.6% in the first quarter. National Pension Service now owns 732,038 shares of the company’s stock worth $23,945,000 after buying an additional 57,726 shares during the last quarter. Bank of Montreal Can raised its position in shares of Teva Pharmaceutical Industries Limited by 5.4% in the first quarter. Bank of Montreal Can now owns 638,426 shares of the company’s stock worth $20,486,000 after buying an additional 32,960 shares during the last quarter. Finally, Gradient Investments LLC raised its position in shares of Teva Pharmaceutical Industries Limited by 3,676.5% in the first quarter. Gradient Investments LLC now owns 7,704 shares of the company’s stock worth $247,000 after buying an additional 7,500 shares during the last quarter. Institutional investors and hedge funds own 56.27% of the company’s stock.

Teva Pharmaceutical Industries Limited (NYSE TEVA) opened at 17.30 on Friday. The company’s 50-day moving average is $29.64 and its 200-day moving average is $31.56. Teva Pharmaceutical Industries Limited has a 12 month low of $16.81 and a 12 month high of $55.39. The stock’s market capitalization is $17.58 billion.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) last released its quarterly earnings results on Thursday, August 3rd. The company reported $0.99 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.06 by $0.07. The firm had revenue of $5.69 billion for the quarter, compared to analysts’ expectations of $5.72 billion. Teva Pharmaceutical Industries Limited had a negative net margin of 25.18% and a positive return on equity of 15.96%. The business’s quarterly revenue was up 12.9% compared to the same quarter last year. During the same period in the previous year, the company posted $1.25 earnings per share. Equities research analysts forecast that Teva Pharmaceutical Industries Limited will post $4.32 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 14th. Shareholders of record on Tuesday, August 29th will be given a dividend of $0.085 per share. This represents a $0.34 annualized dividend and a dividend yield of 1.97%. The ex-dividend date is Friday, August 25th. Teva Pharmaceutical Industries Limited’s payout ratio is -18.95%.

COPYRIGHT VIOLATION NOTICE: “Teva Pharmaceutical Industries Limited (TEVA) Stake Cut by Mitsubishi UFJ Kokusai Asset Management Co. Ltd.” was posted by Community Financial News and is owned by of Community Financial News. If you are viewing this report on another publication, it was illegally stolen and republished in violation of United States & international copyright laws. The original version of this report can be viewed at https://www.com-unik.info/2017/08/12/teva-pharmaceutical-industries-limited-teva-stake-cut-by-mitsubishi-ufj-kokusai-asset-management-co-ltd.html.

A number of equities analysts have recently commented on TEVA shares. Vetr raised shares of Teva Pharmaceutical Industries Limited from a “sell” rating to a “hold” rating and set a $32.27 price target on the stock in a report on Wednesday, June 28th. Royal Bank Of Canada reissued an “outperform” rating and issued a $38.00 price target (down previously from $42.00) on shares of Teva Pharmaceutical Industries Limited in a report on Monday, May 15th. Zacks Investment Research raised shares of Teva Pharmaceutical Industries Limited from a “sell” rating to a “hold” rating in a report on Monday, April 17th. Piper Jaffray Companies reissued a “neutral” rating and issued a $23.00 price target (down previously from $28.00) on shares of Teva Pharmaceutical Industries Limited in a report on Friday, August 4th. Finally, Wells Fargo & Company reissued a “market perform” rating on shares of Teva Pharmaceutical Industries Limited in a report on Saturday, April 29th. Three research analysts have rated the stock with a sell rating, nineteen have assigned a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. Teva Pharmaceutical Industries Limited has a consensus rating of “Hold” and an average target price of $37.69.

About Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited is a pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Company operates through two segments: Generic medicines and Specialty medicines. The Company develops, manufactures and sells generic medicines in a range of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams.

Want to see what other hedge funds are holding TEVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teva Pharmaceutical Industries Limited (NYSE:TEVA).

Institutional Ownership by Quarter for Teva Pharmaceutical Industries Limited (NYSE:TEVA)

What are top analysts saying about Teva Pharmaceutical Industries Limited? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Teva Pharmaceutical Industries Limited and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit